FDA Inspection 955040 — Eurofins Pharma Quality Control
The FDA completed an inspection of Eurofins Pharma Quality Control on December 8, 2015 in Ste Croix en Plaine. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ste Croix en Plaine (France)